Suosituin ja johdonmukaisin upotusväline kryotomialle

Tissue-Tek OCT -yhdistettä käytetään tuoreiden kudosnäytteiden upottamiseen pakastettuihin leikkeisiin kryostaattia käyttämällä. Tissue-Tek OCT -yhdiste on kirkkaiden, vesiliukoisten glykolien ja hartsien formulaatio, joka tarjoaa kiinteän matriisin kapseloimaan kudosnäytteet ja sitoutumaan näytepidikkeeseen johdonmukaisen leikkauksen suorittamiseksi kryostaatin käyttölämpötilassa -10 ° C ja alle.

Ei-toivottu taustavärjäys eliminoidaan, koska dioissa ei ole jäännöksiä värjäyksen aikana.

OCT tarkoittaa optimaalista leikkuulämpötilaa. Tissue-Tek OCT -yhdisteen korkea viskositeetti johtaa nopeaan jäätymiseen optimaalisen leikkauslaadun saavuttamiseksi.

MMA-yhdistettä myydään 118 ml: n puristuspulloissa; 12 / tapaus.

Tissue-Tek OCT: n kryoon upottava yhdiste (yhdiste 4583) on vesiliukoinen PVA: n, glykolien ja hartsien seos, joka tarjoaa stabiilin matriisin näytteiden ympärille kryostaattikudoksen leikkaamista varten lämpötiloissa -10 ° C ja alle. Tissue-Tek on geeli huoneenlämpötilassa, mutta kiinteytyy -10 ° C: ssa ja alle. Se voidaan poistaa helposti vedellä ja / tai alkoholilla huoneenlämmössä.

Vaikka se on alun perin kehitetty ja optimoitu patologialaboratorioiden kryostaattiosastointia varten, Tissue-Tek OCT-upotusyhdiste on myös erinomainen kiinnitysväline käytettäväksi kryo-SEM: n, kryo-FIB / SEM: n ja muiden kylmävaiheiden kanssa (esim. Quorum, Leica, Gatan). Tissue-Tek OCT -yhdiste on luonteeltaan johtamaton materiaali, mutta johtavuus voidaan lisätä sekoittamalla se hiilijauheen tai kolloidisen grafiitin kanssa kryo-SEM-sovelluksiin.

Accu-Tell COVID-19 IgG/IgM Rapid Test
GEN-B352-40tests	Accu test	40 tests	EUR 385.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Chlamydia Rapid Test Device (Swab/Urine)
173-8537306	Abbott	20 Tests/Kit	EUR 300

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody
abx411283-02mg	Abbexa	0.2 mg	EUR 678

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)
abx411284-01mg	Abbexa	0.1 mg	EUR 610.8

Anti-BTLA Neutralizing Antibody
100244	BPS Bioscience	100 µg	EUR 355
Description: This anti-BTLA antibody is a purified recombinant human monoclonal antibody which recognizes the human BTLA protein. BTLA (B- and T-lymphocyte attenuator) belongs to the CD28 immunoglobulin superfamily (IgSF) and is an immune-regulatory receptor that binds to HVEM (Herpesvirus entry mediator, also known as TNFRSF14, Tumor necrosis factor receptor superfamily member 14). This antibody has been tested for specific binding to purified human BTLA protein and neutralizes the interaction between BTLA and HVEM.

Anti-VEGF Neutralizing Antibody
79478-1	BPS Bioscience	50 µg	EUR 355
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.

Anti-VEGF Neutralizing Antibody
79478-2	BPS Bioscience	100 g	EUR 460
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.

Anti-LAG3, Neutralizing Antibody
71219	BPS Bioscience	100 µg	EUR 530
Description: Neutralizing recombinant human antibody recognizing the Lag-3 binding region.

Anti-VISTA Neutralizing Antibody
101293	BPS Bioscience	100 µg	EUR 450
Description: This human monoclonal antibody recognizes human V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA), and neutralizes its interaction with VSIG3 (also called IGSF11). VISTA is also known as B7-H5 or VSIR (GenBank Accession No. NM_022153). VSIG3 is a ligand involved in cell adhesion as a VISTA binding partner. This neutralizing antibody has been functionally tested using the VSIG-3:VISTA [Biotinylated] Inhibitor Screening Assay Kit (BPS Bioscience #79782).

Anti-RANKL Neutralizing Antibody
100874-1	BPS Bioscience	50 µg	EUR 335
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Anti-RANKL Neutralizing Antibody
100874-2	BPS Bioscience	100 µg	EUR 460
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Anti-PCSK9 Neutralizing Antibody
71207	BPS Bioscience	50 µg	EUR 555
Description: Neutralizing recombinant human antibody (IgG1) recognizing the LDLR binding region of human PCSK9.

Anti-TIGIT Neutralizing Antibody
71340	BPS Bioscience	100 µg	EUR 565
Description: Human Anti-TIGIT neutralizing antibody recognizing the TIGIT binding region on immune cells.

Anti-PD-1 Neutralizing Antibody
71120	BPS Bioscience	100 µg	EUR 465
Description: Neutralizing recombinant murine/human chimeric antibody recognizing the PD-L1/PD-L2 binding region of human PD-1. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species.

Anti-IL-17A Neutralizing Antibody
91015	BPS Bioscience	100 µg	EUR 490
Description: Neutralizing recombinant human_x000D_chimeric antibody recognizing human IL-17A._x000D_This antibody has not been tested for crossreactivity_x000D_with other species.

Interferon alpha Neutralizing Antibody
20-abx137013	Abbexa	EUR 427.20 EUR 627.60	0.5 mg 1 mg

Anti-β-Amyloid Neutralizing Antibody
71223	BPS Bioscience	100 µg	EUR 465
Description: Purified, recombinant, humanized Anti-β-amyloid (IgG1) antibody, expressed in HEK293 cells. This antibody reacts with human β-amyloid and has not been tested for cross-reactivity with other species.

Anti-CTLA4 (CD152) Neutralizing Antibody
71212	BPS Bioscience	100 µg	EUR 490
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species.

Anti-PD-L1 (CD274) Neutralizing Antibody
71213	BPS Bioscience	100 µg	EUR 505
Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested.

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)
IOV87952	INVBIO	20T/kit	EUR 46.8
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Monoclonal NGF/proNGF Neutralizing Antibody Antibody
AMM06679G	Leading Biology	0.05mg	EUR 633.6
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E

COVID-19 IgG/IgM Rapid Test Kit
UNCOV-20	UnScience	20T/kit	EUR 186
Description: COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in serum, plasma, or whole blood. This test consists of two test lines, an IgG line and an IgM line, which is pre-coated with two mouse anti-human monoclonal antibodies separately. During testing, the sample reacts with COVID-19 antigen-coated on conjugated pad. As the complex continues to travel up the strip, the anti-COVID-19 IgM antibodies are bound on the IgM line, and the anti-COVID-19 IgG antibodies are bound on the IgG line. The control(C)line appears when sample has flowed through the strip. The presence of anti-COVID-19 IgM and/or IgG will be indicated by a visible test line in the IgM and IgG region. To serve as a procedural control, the control line should always appear if the test procedure is performed properly and the reagents are working as intended.